| HUMAN-TRIAL | Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk NCT07619495 · matched on "Semaglutide" | human-observational | 120000 | not preregistered | — |
| HUMAN-TRIAL | Weight Loss in Adults Using Semaglutide (Real-world Study) NCT07627074 · matched on "Semaglutide" | human-observational | 35000 | industry-funded, not preregistered | — |
| HUMAN-TRIAL | Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity NCT03574597 · matched on "Semaglutide" | human-rct | 17604 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight NCT05567796 · matched on "Semaglutide" | human-rct | 3400 | industry-funded | — |
| HUMAN-TRIAL | GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study NCT07588984 · matched on "Semaglutide" | human-observational | 2310 | industry-funded | — |
| HUMAN-TRIAL | STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity NCT03548935 · matched on "Semaglutide" | human-rct | 1961 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) NCT05646706 · matched on "Semaglutide" | human-rct | 1407 | industry-funded | — |
| HUMAN-TRIAL | Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity NCT03552757 · matched on "Semaglutide" | human-rct | 1210 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight NCT05394519 · matched on "Semaglutide" | human-rct | 1200 | industry-funded | — |
| HUMAN-TRIAL | AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight NCT07400107 · matched on "Semaglutide" | human-rct | 1000 | industry-funded | — |
| HUMAN-TRIAL | Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1) NCT05035095 · matched on "Semaglutide" | human-rct | 667 | industry-funded | — |
| HUMAN-TRIAL | A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide NCT07668414 · matched on "Semaglutide" | human-rct | 650 | industry-funded | — |
| HUMAN-TRIAL | Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program NCT03611582 · matched on "Semaglutide" | human-rct | 611 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term NCT07011667 · matched on "Semaglutide" | human-rct | 609 | industry-funded | — |
| HUMAN-TRIAL | A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity NCT07285902 · matched on "Semaglutide" | human-rct | 572 | industry-funded, not blinded | — |
| HUMAN-TRIAL | STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss NCT06571383 · matched on "Semaglutide" | not determined | 500 | industry-funded, not blinded | — |
| HUMAN-TRIAL | WEgovy Real World Assessment of Weight Loss in Korea NCT07280221 · matched on "Semaglutide" | human-observational | 500 | industry-funded, not preregistered | — |
| HUMAN-TRIAL | Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis NCT05064735 · matched on "Semaglutide" | human-rct | 407 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity NCT06780449 · matched on "Semaglutide" | human-rct | 400 | industry-funded | — |
| HUMAN-TRIAL | Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity. NCT04251156 · matched on "Semaglutide" | human-rct | 375 | industry-funded | — |
| HUMAN-TRIAL | BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity NCT07622810 · matched on "Semaglutide" | human-rct | 352 | industry-funded, not blinded | — |
| HUMAN-TRIAL | Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity NCT04074161 · matched on "Semaglutide" | human-rct | 338 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight NCT05813925 · matched on "Semaglutide" | human-rct | 331 | industry-funded | — |
| HUMAN-TRIAL | Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range NCT05564117 · matched on "Semaglutide" | human-rct | 307 | industry-funded | — |
| HUMAN-TRIAL | Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity NCT03693430 · matched on "Semaglutide" | human-rct | 304 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight NCT05996848 · matched on "Semaglutide" | human-rct | 300 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity NCT07597018 · matched on "Semaglutide" | human-rct | 234 | industry-funded, not blinded | — |
| HUMAN-TRIAL | A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity NCT07639021 · matched on "Semaglutide" | human-rct | 230 | industry-funded | — |
| HUMAN-TRIAL | Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists. NCT07653412 · matched on "Semaglutide" | human-observational | 220 | not preregistered | — |
| HUMAN-TRIAL | PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults NCT06863363 · matched on "Semaglutide" | human-rct | 212 | not blinded | — |
| HUMAN-TRIAL | Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes NCT05040971 · matched on "Semaglutide" | human-rct | 207 | industry-funded | — |
| HUMAN-TRIAL | Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity NCT05132088 · matched on "Semaglutide" | human-rct | 201 | industry-funded | — |
| HUMAN-TRIAL | A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity NCT04102189 · matched on "Semaglutide" | human-rct | 201 | industry-funded | — |
| HUMAN-TRIAL | Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation NCT06499857 · matched on "Semaglutide" | human-rct | 200 | none stated | — |
| HUMAN-TRIAL | Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study NCT07275697 · matched on "Semaglutide" | human-rct | 200 | none stated | — |
| HUMAN-TRIAL | Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3) NCT05890976 · matched on "Semaglutide" | human-rct | 200 | industry-funded | — |
| HUMAN-TRIAL | Semaglutide for Post-Smoking Cessation Weight Management NCT06173778 · matched on "Semaglutide" | human-rct | 197 | none stated | — |
| HUMAN-TRIAL | Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study NCT06820047 · matched on "Semaglutide" | human-observational | 190 | not preregistered | — |
| HUMAN-TRIAL | [The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario]. PMID 39512012 · DOI 10.20960/nh.05244 · matched on "semaglutida" | human-observational | 179 | none stated | 2024-12-19 |
| HUMAN-TRIAL | Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity NCT06771115 · matched on "Semaglutide" | human-rct | 176 | industry-funded, not preregistered | — |
| HUMAN-TRIAL | Sit Less, Interact and Move More (SLIMM) 2 Study NCT05173714 · matched on "Semaglutide" | human-rct | 156 | none stated | — |
| HUMAN-TRIAL | First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes NCT04259801 · matched on "Semaglutide" | human-rct | 152 | industry-funded | — |
| HUMAN-TRIAL | MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial NCT07505303 · matched on "Semaglutide" | human-rct | 151 | industry-funded | — |
| HUMAN-TRIAL | Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity NCT04998136 · matched on "Semaglutide" | human-rct | 150 | industry-funded | — |
| HUMAN-TRIAL | Protein Supplementation Intervention on Body Weight NCT06989203 · matched on "Semaglutide" | human-rct | 140 | not blinded | — |
| HUMAN-TRIAL | Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo NCT06577090 · matched on "Semaglutide" | human-rct | 136 | industry-funded | — |
| HUMAN-TRIAL | A Study of a Novel Precision Medicine Approach For Obesity NCT06814938 · matched on "Semaglutide" | human-rct | 135 | industry-funded | — |
| HUMAN-TRIAL | Semaglutide to Reduce Atrial Fibrillation Burden NCT05209165 · matched on "Semaglutide" | human-rct | 132 | none stated | — |
| HUMAN-TRIAL | Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity NCT07021937 · matched on "Semaglutide" | human-rct | 120 | none stated | — |
| HUMAN-TRIAL | Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs NCT07589322 · matched on "Semaglutide" | human-rct | 120 | not preregistered, not blinded | — |
| HUMAN-TRIAL | A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) NCT07101939 · matched on "Semaglutide" | human-rct | 120 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity NCT04969939 · matched on "Semaglutide" | human-rct | 120 | industry-funded | — |
| HUMAN-TRIAL | A Study of CS060380 Tablets in Patients With MASH and Obesity NCT07466017 · matched on "Semaglutide" | human-rct | 120 | none stated | — |
| HUMAN-TRIAL | Lifestyle Counseling and Medication for Adolescent Weight Management NCT04873245 · matched on "Semaglutide" | human-rct | 120 | not blinded | — |
| HUMAN-TRIAL | A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist NCT06500429 · matched on "Semaglutide" | human-rct | 120 | industry-funded, not preregistered | — |
| HUMAN-TRIAL | Latino Semaglutide Study NCT05087342 · matched on "Semaglutide" | human-rct | 119 | industry-funded | — |
| HUMAN-TRIAL | A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens NCT04238962 · matched on "Semaglutide" | human-rct | 111 | industry-funded, not blinded | — |
| HUMAN-TRIAL | Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc NCT04189848 · matched on "Semaglutide" | human-rct | 104 | industry-funded, not preregistered | — |
| HUMAN-TRIAL | Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure NCT06423599 · matched on "Semaglutide" | human-rct | 100 | not preregistered | — |
| HUMAN-TRIAL | Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health) NCT07527195 · matched on "Semaglutide" | human-rct | 100 | industry-funded | — |
| HUMAN-TRIAL | Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination NCT07294950 · matched on "Semaglutide" | human-rct | 98 | not blinded | — |
| HUMAN-TRIAL | A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese NCT03600480 · matched on "Semaglutide" | human-rct | 96 | industry-funded | — |
| HUMAN-TRIAL | A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese NCT03707990 · matched on "Semaglutide" | human-rct | 88 | industry-funded | — |
| HUMAN-TRIAL | A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906 NCT05751226 · matched on "Semaglutide" | human-rct | 88 | industry-funded | — |
| HUMAN-TRIAL | Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction NCT05371496 · matched on "Semaglutide" | human-rct | 81 | none stated | — |
| HUMAN-TRIAL | A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet NCT07184086 · matched on "Semaglutide" | human-rct | 80 | industry-funded, not blinded | — |
| HUMAN-TRIAL | Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected) NCT07225816 · matched on "Semaglutide" | human-observational | 71 | industry-funded, not blinded | — |
| HUMAN-TRIAL | Real-world effectiveness of oral semaglutide on body weight, composition, and metabolic parameters in patients with obesity without diabetes. PMID 41722140 · DOI 10.1016/j.medcli.2026.107364 · matched on "semaglutida" | human-observational | 70 | none stated | 2026-04-01 |
| HUMAN-TRIAL | Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice NCT07302802 · matched on "Semaglutide" | human-observational | 70 | industry-funded, not preregistered | — |
| HUMAN-TRIAL | A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity NCT04187300 · matched on "Semaglutide" | human-rct | 68 | industry-funded, not blinded | — |
| HUMAN-TRIAL | Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity NCT07293325 · matched on "Semaglutide" | human-rct | 66 | not preregistered, not blinded | — |
| HUMAN-TRIAL | Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. NCT07242534 · matched on "Semaglutide" | human-rct | 62 | not blinded | — |
| HUMAN-TRIAL | Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults NCT07513168 · matched on "Semaglutide" | not determined | 60 | not preregistered, not blinded | — |
| HUMAN-TRIAL | A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults NCT07465965 · matched on "Semaglutide" | human-rct | 60 | industry-funded | — |
| HUMAN-TRIAL | A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity NCT05236517 · matched on "Semaglutide" | human-rct | 60 | industry-funded | — |
| HUMAN-TRIAL | Comparison of Body Composition Changes With Weight Loss Interventions NCT07115069 · matched on "Semaglutide" | human-observational | 60 | none stated | — |
| HUMAN-TRIAL | Semaglutide's Weight Loss Effects in Obesity NCT06825793 · matched on "Semaglutide" | human-observational | 56 | not blinded | — |
| HUMAN-TRIAL | Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity NCT07319975 · matched on "Semaglutide" | human-rct | 48 | none stated | — |
| HUMAN-TRIAL | Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease NCT06344247 · matched on "Semaglutide" | human-rct | 48 | not preregistered, not blinded | — |
| HUMAN-TRIAL | Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial. PMID 42189538 · DOI 10.1001/jamanetworkopen.2026.14898 · matched on "Semaglutide" | human-rct | 45 | none stated | 2026-05-01 |
| HUMAN-TRIAL | Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500 · matched on "Semaglutide" | human-rct | 40 | none stated | — |
| HUMAN-TRIAL | A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese NCT03574584 · matched on "Semaglutide" | human-rct | 37 | industry-funded | — |
| HUMAN-TRIAL | Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women NCT07057310 · matched on "Semaglutide" | human-rct | 30 | not preregistered | — |
| HUMAN-TRIAL | A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity NCT04012255 · matched on "Semaglutide" | human-rct | 29 | industry-funded, not blinded | — |
| HUMAN-TRIAL | A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver NCT05202353 · matched on "Semaglutide" | human-rct | 29 | industry-funded, not blinded | — |
| HUMAN-TRIAL | A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide NCT04228354 · matched on "Semaglutide" | human-rct | 28 | industry-funded | — |
| HUMAN-TRIAL | Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes NCT07317115 · matched on "Semaglutide" | human-rct | 20 | industry-funded, not blinded | — |
| HUMAN-TRIAL | Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects. NCT05419726 · matched on "Semaglutide" | human-observational | 20 | none stated | — |
| HUMAN-TRIAL | Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients NCT06754163 · matched on "Semaglutide" | not determined | 20 | not blinded | — |
| HUMAN-TRIAL | A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity NCT06716307 · matched on "Semaglutide" | human-rct | 18 | industry-funded, not blinded | — |
| HUMAN-TRIAL | Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy NCT04741074 · matched on "Semaglutide" | human-rct | 15 | none stated | — |
| HUMAN-TRIAL | Effect of Semaglutide in Patients With Psoriasis and Obesity NCT06937060 · matched on "Semaglutide" | not determined | 14 | not preregistered, not blinded | — |
| HUMAN-TRIAL | Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) NCT07223983 · matched on "Semaglutide" | human-rct | 10 | none stated | — |
| HUMAN-TRIAL | The Effects of Semaglutide on Body Composition and Performance in Military Personnel NCT06468748 · matched on "Semaglutide" | not determined | 0 | not blinded | — |
| HUMAN-TRIAL | Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study. PMID 42495930 · DOI 10.1080/01443615.2026.2701996 · matched on "Semaglutide" | human-observational | — | none stated | 2026-12-01 |
| HUMAN-TRIAL | Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg Injectable: An Indirect Treatment Comparison of Weight Loss Outcomes. PMID 42225300 · DOI 10.1111/dom.70911 · matched on "Semaglutide" | human-rct | — | none stated | 2026-08-01 |
| HUMAN-TRIAL | Implementation of the IWQOL-Lite-CT in Observational Research: Comparison of Baseline Scores With a Clinical Trial Population and Psychometric Evaluation. PMID 42235931 · DOI 10.1111/cob.70087 · matched on "Semaglutide" | human-observational | — | none stated | 2026-08-01 |
| HUMAN-TRIAL | Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial. PMID 42308057 · DOI 10.2215/cjn.0000001051 · matched on "Semaglutide" | human-rct | — | none stated | 2026-07-01 |
| HUMAN-TRIAL | Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study. PMID 42174244 · DOI 10.1007/s11695-026-08748-5 · matched on "Semaglutide" | human-observational | — | none stated | 2026-07-01 |
| HUMAN-TRIAL | Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial. PMID 42120723 · DOI 10.1038/s41591-026-04386-7 · matched on "Semaglutide" | human-rct | — | none stated | 2026-07-01 |
| HUMAN-TRIAL | Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. PMID 41865857 · DOI 10.1016/j.amjmed.2026.03.010 · matched on "Semaglutide" | human-rct | — | none stated | 2026-07-01 |
| HUMAN-TRIAL | Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial. PMID 42174253 · DOI 10.1038/s41591-026-04416-4 · matched on "Semaglutide" | human-rct | — | none stated | 2026-07-01 |
| HUMAN-TRIAL | Preoperative GLP-1 Receptor Agonists and Thromboinflammatory Markers in Patients Undergoing Abdominoplasty: A Prospective Monocentric Study. PMID 41944875 · DOI 10.1007/s00266-026-05805-3 · matched on "Semaglutide" | human-observational | — | none stated | 2026-06-01 |
| HUMAN-TRIAL | SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials. PMID 41884974 · DOI 10.1111/dom.70697 · matched on "Semaglutide" | human-observational | — | none stated | 2026-06-01 |
| HUMAN-TRIAL | Real-world use of semaglutide for obesity treatment: A cohort study in an integrated health care delivery system. PMID 42166306 · DOI 10.18553/jmcp.2026.32.6.660 · matched on "Semaglutide" | human-observational | — | none stated | 2026-06-01 |
| HUMAN-TRIAL | Combining GLP-1 Receptor Agonists and Health-Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real-World Single-Center Study. PMID 42222894 · DOI 10.1111/ijpo.70122 · matched on "Semaglutide" | human-observational | — | none stated | 2026-06-01 |
| HUMAN-TRIAL | BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia. PMID 42381378 · DOI 10.1080/03007995.2026.2692167 · matched on "Semaglutide" | human-observational | — | none stated | 2026-05-01 |
| HUMAN-TRIAL | Toward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical Practice. PMID 42124020 · DOI 10.3390/nu18091419 · matched on "Semaglutide" | human-observational | — | none stated | 2026-04-30 |
| HUMAN-TRIAL | Comparison of Semaglutide and Lifestyle Counselling for Weight Loss Using Multi-Site Electronic Health Records. PMID 41830068 · DOI 10.1111/cob.70076 · matched on "Semaglutide" | human-observational | — | none stated | 2026-04-01 |
| HUMAN-TRIAL | Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. PMID 41772149 · DOI 10.1038/s41591-026-04204-0 · matched on "Semaglutide" | human-rct | — | none stated | 2026-03-01 |
| ANIMAL | Chronic semaglutide alters ingestive behavior without impairing taste function in mice. PMID 42364710 · DOI 10.1016/j.molmet.2026.102410 · matched on "Semaglutide" | animal | — | none stated | 2026-08-01 |
| ANIMAL | The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors. PMID 41985454 · DOI 10.1016/j.cmet.2026.03.011 · matched on "Semaglutide" | animal | — | none stated | 2026-07-07 |
| ANIMAL | 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss. PMID 42228536 · DOI 10.1073/pnas.2606533123 · matched on "Semaglutide" | animal | — | none stated | 2026-06-09 |
| ANIMAL | Repeated semaglutide treatment attenuates cocaine-vs-food choice in male and female rats. PMID 41986468 · DOI 10.1038/s41386-026-02386-2 · matched on "Semaglutide" | animal | — | none stated | 2026-06-01 |
| ANIMAL | Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons. PMID 42174184 · DOI 10.1038/s42255-026-01534-8 · matched on "Semaglutide" | animal | — | none stated | 2026-06-01 |
| ANIMAL | Therapeutic efficacy, biomarker signatures, and translatability of semaglutide in the liver biopsy-confirmed GAN DIO-MASH mouse model. PMID 41973550 · DOI 10.1152/ajpgi.00011.2026 · matched on "Semaglutide" | animal | — | none stated | 2026-06-01 |
| ANIMAL | Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity. PMID 41915442 · DOI 10.1172/jci.insight.205174 · matched on "Semaglutide" | animal | — | none stated | 2026-05-22 |
| ANIMAL | Phyllanthus niruri niosomes ameliorate obesity-induced hepatic steatosis in rats via modulating MALAT1/miR-206/GLP-1R signaling and hepatic lipid metabolism. PMID 42045980 · DOI 10.1186/s40659-026-00682-1 · matched on "Semaglutide" | animal | — | none stated | 2026-04-27 |
| ANIMAL | Semaglutide restores metabolic and structural homeostasis along the gut-heart-metabolic axis in a cafeteria diet-induced obesity model. PMID 41872245 · DOI 10.1038/s41598-026-41954-w · matched on "Semaglutide" | animal | — | none stated | 2026-03-23 |
| ANIMAL | D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice. PMID 41754224 · DOI 10.3390/nu18040707 · matched on "Semaglutide" | animal | — | none stated | 2026-02-23 |
| PRECLINICAL | Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. PMID 41877354 · DOI 10.1111/dom.70666 · matched on "Semaglutide" | not determined | 15782 | none stated | 2026-06-01 |
| PRECLINICAL | A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'. PMID 41838446 · DOI 10.1080/02813432.2026.2636584 · matched on "Semaglutide" | not determined | — | none stated | 2026-12-01 |
| PRECLINICAL | Evidence-informed guidance for the clinical use of oral semaglutide in obesity management. PMID 42286992 · DOI 10.1080/00325481.2026.2686467 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Effects of Glucagon-Like Peptide-1 Receptor Agonists (Mono and Combination Therapy) on Energy Expenditure: A Scoping Review. PMID 41782395 · DOI 10.1111/obr.70116 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Weight Loss Medications in Youth: Decision-Making Experiences, Eating Behaviors, and Uncertainty About Endpoint. PMID 42233931 · DOI 10.1016/j.jadohealth.2026.03.017 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Risk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor Agonists. PMID 42259622 · DOI 10.1111/dom.70975 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Beyond weight loss: multisystem benefits of obesity medications. PMID 42208956 · DOI 10.1016/s2213-8587(26)00100-2 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Weight-Lowering Drugs and Natural Female Fertility-A Systematic Review and Meta-Analysis. PMID 42307450 · DOI 10.1111/cob.70092 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Real-World Effectiveness and 12-Month Persistence of a Semaglutide-Supported Digital Weight-Loss Service: A Retrospective Cohort Study in Germany. PMID 42186215 · DOI 10.1111/dom.70916 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison. PMID 42225305 · DOI 10.1111/dom.70919 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | A Systematic Review and Meta-Analysis of Semaglutide Effects on Adipose Tissue and Emerging Effects on Brain and Cognition. PMID 41766347 · DOI 10.1111/obr.70108 · matched on "Semaglutide" | not determined | — | none stated | 2026-08-01 |
| PRECLINICAL | Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis. PMID 42419792 · DOI 10.1136/bmj-2026-372161 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-08 |
| PRECLINICAL | GLP-1 and MASH: When weight loss isn't the whole story. PMID 42413474 · DOI 10.1016/j.cmet.2026.06.005 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-07 |
| PRECLINICAL | Postshortage Compounded GLP-1 RA Market in 2 States With Potentially High Demand. PMID 42467450 · DOI 10.1001/jamahealthforum.2026.2207 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-02 |
| PRECLINICAL | Beyond GLP-1 Monotherapy: Novel Multi-Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes. PMID 42098899 · DOI 10.1111/dom.70822 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials. PMID 42207966 · DOI 10.1002/edm2.70248 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity. PMID 42050884 · DOI 10.1111/dom.70773 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | Incretin-Based Anti-obesity Medications in Polycystic Ovary Syndrome: The Evidence Map. PMID 42106472 · DOI 10.1007/s40265-026-02325-x · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review. PMID 41996180 · DOI 10.7326/annals-25-00478 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | Efficacy, Safety and PK of Once-Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model-Informed Drug Development Approach. PMID 42023428 · DOI 10.1111/dom.70769 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review. PMID 41991422 · DOI 10.1016/j.disamonth.2026.102113 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | American Society for Metabolic and Bariatric Surgery statement on the treatment options for patients with non-response and weight recurrence after metabolic and bariatric surgery. PMID 42150970 · DOI 10.1016/j.soard.2026.04.002 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | Knowledge, Attitudes and Practices on the Use of Antidiabetic Medications for Weight Loss: A Cross-Sectional Study in the Lebanese Population. PMID 42447181 · DOI 10.1002/edm2.70286 · matched on "Semaglutide" | not determined | — | none stated | 2026-07-01 |
| PRECLINICAL | [The role of obesity and weight reduction in obstructive sleep apnea]. PMID 42365594 · DOI 10.1556/650.2026.33589 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-28 |
| PRECLINICAL | Cross-sectional analysis of the reliability and engagement metrics of YouTube videos on semaglutide for weight loss. PMID 42260873 · DOI 10.1097/md.0000000000049173 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-05 |
| PRECLINICAL | Fat, muscle, and anti-obesity medications in cardiovascular disease prevention. PMID 41914150 · DOI 10.1093/eurheartj/ehag201 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-02 |
| PRECLINICAL | Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide. PMID 41816857 · DOI 10.1111/dom.70660 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Body image in the age of GLP-1s: Emerging questions for research and practice. PMID 42030632 · DOI 10.1016/j.bodyim.2026.102095 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Childhood obesity and cardiac risk in youth: Emerging challenges toward 2050. PMID 41933725 · DOI 10.1016/j.clnesp.2026.103260 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | GLP-1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta-Analysis of RCTs. PMID 41872986 · DOI 10.1111/dom.70698 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Sequential Intragastric Balloon Followed By GLP-1 Receptor Agonist Therapy in Obesity: A Comparative Study of 12-Month Weight Loss Outcomes. PMID 42026424 · DOI 10.1007/s11695-026-08698-y · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management. PMID 42301877 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Real-world outcomes of hybrid obesity care using digital coaching and GLP-1 therapy in a multi-ethnic Asian setting. PMID 41957114 · DOI 10.1038/s41366-026-02062-x · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Medical nutrition in the glucagon-like peptide-1 (GLP-1) era: Protein strategies, micronutrient monitoring, and lean mass preservation. PMID 42036071 · DOI 10.1016/j.clnesp.2026.103305 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Weight Loss With GLP-1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta-Analysis. PMID 41936548 · DOI 10.1002/oby.70169 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression. PMID 41834765 · DOI 10.1111/dom.70667 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | ICER report demonstrates both the value and challenges in financing of weight loss medications. PMID 42166309 · DOI 10.18553/jmcp.2026.32.6.753 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System. PMID 41739406 · DOI 10.1007/s11096-026-02099-y · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults. PMID 41891334 · DOI 10.1111/dom.70721 · matched on "Semaglutide" | not determined | — | none stated | 2026-06-01 |
| PRECLINICAL | GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. PMID 42280424 · DOI 10.3390/nu18111781 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-31 |
| PRECLINICAL | Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance. PMID 42280393 · DOI 10.3390/nu18111751 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-29 |
| PRECLINICAL | After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care. PMID 42206886 · DOI 10.2196/101874 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-28 |
| PRECLINICAL | To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications. PMID 42183911 · DOI 10.1007/s11883-026-01426-y · matched on "Semaglutide" | not determined | — | none stated | 2026-05-25 |
| PRECLINICAL | Benefits of Incretin Therapy on Ovarian Function: A Scientific Literature Review. PMID 42278283 · DOI 10.3390/ijms27114752 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-25 |
| PRECLINICAL | GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and Behavioral Co-Interventions-A Systematic Review. PMID 42280306 · DOI 10.3390/nu18111662 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-22 |
| PRECLINICAL | Swiss obesity clinical practice guidance. PMID 42312974 · DOI 10.57187/5415 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-19 |
| PRECLINICAL | CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. PMID 41759565 · DOI 10.1016/j.amjcard.2026.02.030 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-15 |
| PRECLINICAL | Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis. PMID 41770554 · DOI 10.1001/jamainternmed.2025.8222 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Semaglutide in obesity and type 2 diabetes: A review of clinical trial evidence from 1 to 5 semaglutide treatment effect in people with obesity program. PMID 42060800 · DOI 10.4103/ijp.ijp_686_25 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Semaglutide in patients with hidradenitis suppurativa and obesity. PMID 41832804 · DOI 10.1016/j.medcli.2026.107405 · matched on "semaglutida" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Comparison of pharmacotherapies for obesity with sleeve gastrectomy: a network meta-analysis and systematic review. PMID 41968780 · DOI 10.1080/17446651.2026.2656247 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Weight loss as the optimal cardiometabolic management strategy for preventing and treating heart failure. PMID 41802118 · DOI 10.1097/hco.0000000000001284 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Genetic predictors of GLP1 receptor agonist weight loss and side effects. PMID 41951734 · DOI 10.1038/s41586-026-10330-z · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | A retrospective audit of weight loss and health outcomes following bariatric surgery at a tertiary public hospital. PMID 42142983 · DOI 10.1016/j.orcp.2026.05.003 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease in People With Obesity. A Systematic Review and Network Meta-Analysis of Randomised Clinical Trials. PMID 41804193 · DOI 10.1111/dom.70617 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Revisional Metabolic and Bariatric Surgery Versus Semaglutide: Which Strategy Has Greater Efficacy for Recurrent Weigh Gain After Primary Bariatric Surgery? PMID 41906069 · DOI 10.1007/s11695-026-08627-z · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Real-world Physical Activity and Sedentary Time Trends in Patients Undergoing Obesity Treatment: Insights From the All of Us Research Program. PMID 41912836 · DOI 10.1007/s11695-026-08645-x · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials. PMID 41820778 · DOI 10.1007/s12325-026-03523-5 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis. PMID 42175595 · DOI 10.1002/edm2.70247 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Emerging natural products against obesity and metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis: Direct target discovery and mechanistic insights. PMID 41950803 · DOI 10.1016/j.pharmr.2026.100125 · matched on "Semaglutide" | not determined | — | none stated | 2026-05-01 |
| PRECLINICAL | Impact of semaglutide pretreatment on reproductive outcomes in women with overweight and obesity with infertility: a real-world multicenter cohort study. PMID 42001071 · DOI 10.1186/s12958-026-01549-6 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-18 |
| PRECLINICAL | Pharmacologic Treatment of Obesity in the Context of Type 2 Diabetes. PMID 41973192 · DOI 10.1007/s11892-026-01626-5 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-13 |
| PRECLINICAL | Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk? PMID 41918364 · DOI 10.1158/1940-6207.capr-26-0018 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-01 |
| PRECLINICAL | Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023. PMID 41741949 · DOI 10.1002/oby.70151 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-01 |
| PRECLINICAL | Obesity Management: Pharmacotherapy. PMID 42101582 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-01 |
| PRECLINICAL | Real-world experience of semaglutide 2.4 mg in the US: a retrospective analysis of profiles, satisfaction, and treatment patterns in people with obesity and overweight. PMID 42312439 · DOI 10.1080/03007995.2026.2689307 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-01 |
| PRECLINICAL | Geriatric Pharmacotherapy Case Series: GLP-1 RA for Weight Management in Older Adults. PMID 41966038 · DOI 10.4140/tcp.n.2026.78 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-01 |
| PRECLINICAL | [Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 2]. PMID 42441680 · DOI 10.4067/s0034-98872026000400564 · matched on "Semaglutide" | not determined | — | none stated | 2026-04-01 |
| PRECLINICAL | GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials. PMID 41824845 · DOI 10.1097/md.0000000000047994 · matched on "Semaglutide" | not determined | — | none stated | 2026-03-13 |
| PRECLINICAL | Resistant and Refractory Obesity: The Complexity of Anti-Obesity Therapy Failure. PMID 41898403 · DOI 10.3390/ijms27062539 · matched on "Semaglutide" | not determined | — | none stated | 2026-03-10 |
| PRECLINICAL | [Obesity: novel pharmacological treatments]. PMID 41802423 · DOI 10.1055/a-2610-3294 · matched on "Semaglutide" | not determined | — | none stated | 2026-03-01 |
| PRECLINICAL | Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma. PMID 42325616 · DOI 10.3389/fendo.2026.1768254 · matched on "Semaglutide" | not determined | — | none stated | 2026-01-01 |
| PRECLINICAL | Beyond weight loss: predictors of treatment satisfaction and patient-reported outcomes in incretin-based therapies. A cross-sectional study. PMID 42388883 · DOI 10.3389/fendo.2026.1864209 · matched on "Semaglutide" | not determined | — | none stated | 2026-01-01 |
| PRECLINICAL | Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination - The REST trial study protocol. PMID 42507673 · DOI 10.1371/journal.pone.0354237 · matched on "Semaglutide" | not determined | — | none stated | 2026-01-01 |
| PRECLINICAL | Expert meeting report: epidemiology and management of acquired hypothalamic obesity. PMID 42064767 · DOI 10.3389/fendo.2026.1798619 · matched on "Semaglutide" | not determined | — | none stated | 2026-01-01 |
| PRECLINICAL | Trends and projections of overweight and obesity among midlife women in the United States, 1990-2050: A sub‑study of the Global Burden of Disease 2021. PMID 41805450 · DOI 10.1177/17455057261430197 · matched on "Semaglutide" | not determined | — | none stated | 2026-01-01 |
| PRECLINICAL | The Role of Glucagon-Like Peptide-1 Receptor Agonists in Prompting a Meaningful Improvement in Alcohol Use Disorder. PMID 41914511 · DOI 10.1177/21501319261437615 · matched on "Semaglutide" | not determined | — | none stated | 2026-01-01 |
| PRECLINICAL | Weight management treatment in obesity. PMID 40865172 · DOI 10.1016/j.medcli.2025.107152 · matched on "semaglutida" | not determined | — | none stated | 2025-11-01 |
| PRECLINICAL | GLP-1 receptor agonists and GIP/GLP-1 co-agonists in the treatment of obesity in adolescents and the elderly. PMID 40716192 · DOI 10.1016/j.medcli.2025.107122 · matched on "semaglutida" | not determined | — | none stated | 2025-10-01 |
| PRECLINICAL | GLP-1-based medications: Mechanisms involved in obesity treatment. PMID 40466247 · DOI 10.1016/j.medcli.2025.107035 · matched on "semaglutida" | not determined | — | none stated | 2025-07-01 |